Concert Pharmaceuticals
Why Robinhood?
You can watch CNCE and buy or sell other stocks, ETFs, and their options commission-free!About CNCE
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders.
CNCE Key Statistics
Stock Snapshot
As of today, Concert Pharmaceuticals(CNCE) shares are valued at $8.37. The company's market cap stands at 401.95M, with a P/E ratio of -2.61.
On 2026-07-25, Concert Pharmaceuticals(CNCE) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.51M.
The stock's 52-week range extends from a low of $2.66 to a high of $8.55.
The stock's 52-week range extends from a low of $2.66 to a high of $8.55.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.